ID: ALA5207590

Max Phase: Preclinical

Molecular Formula: C28H35FN2O4

Molecular Weight: 482.60

Representations

Canonical SMILES:  CCC(CC)O[C@@H]1C=C(C(=O)O)C[C@H](NCc2cc(F)c(-c3ccccc3)cc2C)[C@H]1NC(C)=O

Standard InChI:  InChI=1S/C28H35FN2O4/c1-5-22(6-2)35-26-15-20(28(33)34)14-25(27(26)31-18(4)32)30-16-21-13-24(29)23(12-17(21)3)19-10-8-7-9-11-19/h7-13,15,22,25-27,30H,5-6,14,16H2,1-4H3,(H,31,32)(H,33,34)/t25-,26+,27+/m0/s1

Standard InChI Key:  REPISTRJMLWTBH-OYUWMTPXSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 482.60

Molecular Weight (Monoisotopic): 482.2581

AlogP: 4.75

#Rotatable Bonds: 10

Polar Surface Area: 87.66

Molecular Species: ZWITTERION

HBA: 4

HBD: 3

#RO5 Violations: 0

HBA (Lipinski): 6

HBD (Lipinski): 3

#RO5 Violations (Lipinski): 0

CX Acidic pKa: 4.27

CX Basic pKa: 8.66

CX LogP: 2.41

CX LogD: 2.40

Aromatic Rings: 2

Heavy Atoms: 35

QED Weighted: 0.45

Np Likeness Score: 0.22

References

1. Ju H, Hou L, Zhao F, Zhang Y, Jia R, Guizzo L, Bonomini A, Zhang J, Gao Z, Liang R, Bertagnin C, Kong X, Ma X, Kang D, Loregian A, Huang B, Liu X, Zhan P..  (2022)  Iterative Optimization and Structure-Activity Relationship Studies of Oseltamivir Amino Derivatives as Potent and Selective Neuraminidase Inhibitors via Targeting 150-Cavity.,  65  (17.0): [PMID:35939763] [10.1021/acs.jmedchem.1c01970]

Source

Source(1):

• Scientific Literature